FDA denies Rigel's COVID-19 hopeful Tavalisse for hospitalized patients, asks for...

Quote
cafead

cafead

Administrator
Staff member
  • cafead   Aug 13, 2021 at 11:02: AM
via The FDA has authorized a few of drugs for emergency use in hospitalized COVID-19 patients, but Rigel Pharmaceuticals’ autoimmune disease drug Tavalisse won’t be joining the group right now.

article source
 

<



Similar threads

cafead
FDA Denies Accelerated Approval for Clene’s ALS Candidate
Replies
0
Views
218
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
FDA denies expanded approval for Alnylam RNA drug
Replies
0
Views
103
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
FDA Denies Outlook’s Wet AMD Bid, Issues Complete Response Letter
Replies
0
Views
227
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
Byondis&#039; breast cancer drug fails to bloom as FDA denies approval
Replies
0
Views
176
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
Pharma company continues its FDA lawsuit spree, this time after agency denies fast-track...
Replies
0
Views
175
Pharma/Biotech Companies - In the News
cafead
cafead
Top Bottom
Back
Quote